124 related articles for article (PubMed ID: 25024662)
1. Resolution of severe obstructive sleep apnea after treatment of anti-muscle kinase receptor-positive myasthenia gravis despite 60-pound weight gain.
Morgenstern M; Singas E; Zleik B; Greenberg H
J Clin Sleep Med; 2014 Jul; 10(7):813-4. PubMed ID: 25024662
[TBL] [Abstract][Full Text] [Related]
2. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
Yamada C; Teener JW; Davenport RD; Cooling L
J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
[TBL] [Abstract][Full Text] [Related]
3. Sleep Disordered Breathing Mimicking Myasthenia Crisis in a Patient with Myasthenia Gravis.
Lai YC; Chen JY; Wu HD; Yang CC; Lin CH; Lee PL
J Clin Sleep Med; 2016 May; 12(5):767-9. PubMed ID: 26943715
[TBL] [Abstract][Full Text] [Related]
4. CPAP therapy reverses weakness of myasthenia gravis: role of obstructive sleep apnea in paradoxical weakness of myasthenia gravis.
Ji KH; Bae JS
J Clin Sleep Med; 2014 Apr; 10(4):441-2. PubMed ID: 24733991
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
Hain B; Jordan K; Deschauer M; Zierz S
Muscle Nerve; 2006 Apr; 33(4):575-80. PubMed ID: 16323216
[TBL] [Abstract][Full Text] [Related]
6. The treatment of severe forms of myasthenia gravis.
Iani C; Caramia M; Morosetti M; Loberti M; Palmieri MG; Meloni C; Gallucci MT; Casciani CU; Bernardi G
Funct Neurol; 1998; 13(3):231-7. PubMed ID: 9800150
[TBL] [Abstract][Full Text] [Related]
7. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
Guptill JT; Sanders DB; Evoli A
Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
[TBL] [Abstract][Full Text] [Related]
8. A 23-Year-Old Man With Dyspnea During Myasthenia Crisis.
Weinberg M; Cavalcante JA; Choy T; Ahmad S
Chest; 2019 Jun; 155(6):e155-e157. PubMed ID: 31174658
[No Abstract] [Full Text] [Related]
9. Seronegative myasthenia gravis and human immunodeficiency virus infection: response to intravenous gamma globulin and prednisone.
Strong J; Zochodne DW
Can J Neurol Sci; 1998 Aug; 25(3):254-6. PubMed ID: 9706730
[TBL] [Abstract][Full Text] [Related]
10. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
11. Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome?
Bhagavati S; Maccabee PJ; Chari G
Eur J Neurol; 2007 Aug; 14(8):e21-2. PubMed ID: 17661994
[No Abstract] [Full Text] [Related]
12. COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.
Singh S; Govindarajan R
Clin Neurol Neurosurg; 2020 Sep; 196():106045. PubMed ID: 32634699
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of obstructive sleep apnea in myasthenia gravis patients: a single center study.
Heo SJ; Jun JS; Park D; Lee HW; Kim JS; Park JS
Neurol Sci; 2019 Apr; 40(4):719-724. PubMed ID: 30648206
[TBL] [Abstract][Full Text] [Related]
14. Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review.
Hehir MK; Hobson-Webb LD; Benatar M; Barnett C; Silvestri NJ; Howard JF; Howard D; Visser A; Crum BA; Nowak R; Beekman R; Kumar A; Ruzhansky K; Chen IA; Pulley MT; LaBoy SM; Fellman MA; Greene SM; Pasnoor M; Burns TM
Neurology; 2017 Sep; 89(10):1069-1077. PubMed ID: 28801338
[TBL] [Abstract][Full Text] [Related]
15. Maxillary deformity following CPAP treatment in myasthenia gravis.
Haviv Y; Leibovitz S; Almoznino G; Sharav Y; Zilberman U
Cranio; 2018 Nov; 36(6):404-407. PubMed ID: 28675961
[TBL] [Abstract][Full Text] [Related]
16. [Favorable results of plasmapheresis in severe myasthenia gravis].
Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
[TBL] [Abstract][Full Text] [Related]
17. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
Reddel SW; Morsch M; Phillips WD
Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
[TBL] [Abstract][Full Text] [Related]
18. Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis.
Punga T; Bartoccioni E; Lewandowska M; Damato V; Evoli A; Punga AR
J Neuroimmunol; 2016 Mar; 292():21-6. PubMed ID: 26943954
[TBL] [Abstract][Full Text] [Related]
19. [Respiratory disorders during sleep and myasthenia].
Gajdos P; Quera Salva MA
Rev Neurol (Paris); 2001 Nov; 157(11 Pt 2):S145-7. PubMed ID: 11924028
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
